comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 00:35:59 - browse：698

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Amazon on where the company's health care bets are headed next

WSS

The UK government moves asylum

Medicaid rebukes states for mistakenly disenrolling children

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

In medicine, common shorthands can shortchange care

Illinois to ban advertising for guns allegedly marketed to kids and militants

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

entertainment

comprehensive

leisure time

In age of alternative facts, a scholarly course on calling out crap

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

What does generative AI mean for health care? We asked experts

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Novavax promises a turnaround & Lilly roils the obesity market

What drug price negotiations mean for Medicare Part D

United colonoscopy coverage change 'may cost lives,' doctors say

Why workplace violence is so common in health care

As demand for Covid shots wanes, Moderna seeks its next success

Stem cell treatment guidelines are released by FDA

Wikipedia

The UK government moves asylum

'Make People Better': The CRISPR babies story you probably don't know

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Trump Jan. 6 attorney John Lauro is ex

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Amazon on where the company's health care bets are headed next

hotspot

focus

entertainment

explore